http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4693254-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d00b02f845cc4d1e9ff04196a105ccf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37235
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3603
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-34
filingDate 1986-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50439bae84d439abd5735a6caf04d439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c2e7b3f17133b494306ad83c90fb672
publicationDate 1987-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4693254-A
titleOfInvention Transcutaneous nerve stimulation device using a common controller for pulse production and parameter display
abstract A transcutaneous nerve stimulation device is provided using a common controller for both output pulse production and treatment parameter display. The common controller, which preferentially takes the form of a programmed microprocessor, is connected by signal lines to both the pulse output circuitry and the display, which are controlled by time-sharing the signal lines. The controller is responsive to operator entered input signals for the calculation of output pulse characteristics and display parameters. During a majority of treatment time, the controller is providing signals on the signal lines for control of the display. The display signals are interrupted during timed intervals when output signals are produced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6830550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5487759-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8249713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104619379-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5048522-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6021353-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4926865-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5350414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008065171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792495-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612746-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-607977-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5653735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4996987-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5797854-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004236387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5859527-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6845271-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3235541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008177351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002077572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-397768-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10076663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11540973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8626302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010036454-A1
priorityDate 1984-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4102348-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397217

Total number of triples: 48.